本期内容提示:
1、一大波核心仓位出现建仓机会,优先考虑哪些?
2、又一只有翻倍潜力的成长股临近理想建仓区;
3、$Rxi Pharmaceuticals Corp(PHIO)$ 数据不错,可否追涨?
$恒瑞医药(SH600276)$ $华东医药(SZ000963)$查看全文
Replix锐璞美股2021-03-01 21:16
$Phio Pharmaceuticals(PHIO)$ PHIO PHARMACEUTICALS AND AGONOX, INC. ANNOUNCE COLLABORATION ON CLINICAL DEVELOPMENT OF NOVEL T CELL-BASED CANCER IMMUNOTHERAPIES
Under the terms of the collaboration agreement, AgonOx will receive financial support for the clinical trial from...查看全文
Replix锐璞美股2021-02-18 14:08
$Phio Pharmaceuticals(PHIO)$ 公司增发完毕,看看是否能翻身。
$基因进化ETF-ARK(ARKG)$ $富途控股(FUTU)$查看全文
$Phio Pharmaceuticals(PHIO)$ EFFECT - Notice of Effectiveness Filed: 2019-10-01 AccNo: 9999999995-19-002218 Size: 1 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933 Filed: 2019-09-25 AccNo: 0001683168-19-003041 Size: 310 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ DEF 14A - Other definitive proxy statements Filed: 2019-08-30 AccNo: 0001683168-19-002796 Size: 750 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ S-1 - General form for registration of securities under the Securities Act of 1933 Filed: 2019-08-30 AccNo: 0001683168-19-002795 Size: 387 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2019-08-30 AccNo: 0001683168-19-002797 Size: 265 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ PRE 14A - Other preliminary proxy statements Filed: 2019-08-12 AccNo: 0001683168-19-002542 Size: 737 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-12 AccNo: 0001683168-19-002547 Size: 1 MB 网页链接
$Phio Pharmaceuticals(PHIO)$ 8-K - Current report Filed: 2019-08-12 AccNo: 0001683168-19-002550 Size: 77 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Phio Pharmaceuticals(PHIO)$ 8-K - Current report Filed: 2019-08-09 AccNo: 0001683168-19-002524 Size: 368 KBItem 1.01: Entry into a Material Definitive AgreementItem 3.02: Unregistered Sales of Equity SecuritiesItem 5.02: Departure of Directors or Certain Officers; Election o...
$Phio Pharmaceuticals(PHIO)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-05-14 AccNo: 0001683168-19-001519 Size: 1 MB 网页链接